Searched over 200M research papers for "vascular disease"
10 papers analyzed
These studies suggest that vascular disease involves complex interactions between platelet-leukocyte interplay, vascular remodeling, genetic variations, and common risk factors, with comprehensive guidelines and advanced treatments improving diagnosis, management, and patient outcomes.
20 papers analyzed
Vascular disease encompasses a range of conditions affecting the blood vessels, including arteries, veins, and lymphatics. It is a significant component of cardiovascular disease (CVD), which remains the leading cause of death globally, with an estimated 17.8 million deaths attributed to CVD in 2017. Vascular diseases can lead to severe health issues such as atherosclerosis, peripheral arterial disease (PAD), and venous thromboembolism (VTE).
Vascular disease is often driven by a combination of lifestyle factors such as physical inactivity, a cholesterol-rich diet, and smoking, along with endogenous factors like age, gender, and autoimmune status. These factors create a pro-inflammatory and pro-thrombotic environment, leading to endothelial dysfunction, atherosclerotic plaque formation, and vascular obstruction. Platelet-leukocyte interactions play a crucial role in this process, as activated platelets interact with immune cells, promoting leukocyte recruitment and enhancing pro-inflammatory responses.
Vascular remodeling is a key process in the progression of vascular diseases. It involves structural changes in the vessel wall, including cell growth, cell death, and extracellular matrix reorganization. This process is essential for maintaining blood pressure homeostasis under normal conditions but can lead to pathological changes in diseases such as hypertension and atherosclerosis. Endothelial cells, vascular smooth muscle cells, and fibroblasts all contribute to these remodeling processes, driven by inflammatory cytokines, hemodynamic stimuli, and growth factors.
PAD primarily affects the arteries supplying the limbs and is most commonly caused by atherosclerosis. It is associated with significant morbidity and mortality, impacting quality of life through symptoms like intermittent claudication and increasing the risk of cardiovascular events . Despite its prevalence, PAD often receives suboptimal treatment compared to coronary artery disease, highlighting the need for better therapeutic strategies and patient management.
Diabetes significantly exacerbates vascular disease, leading to both large vessel (atherosclerotic) and small vessel (microvascular) complications. Diabetic patients are prone to earlier and more severe forms of atherosclerosis, as well as unique microvascular issues such as retinopathy and nephropathy, which are not typically seen in non-diabetics. These complications arise from endothelial proliferation, basement membrane thickening, and the accumulation of mucopolysaccharides, differing from the lipid and fibrotic lesions seen in atherosclerosis.
Recent studies suggest a link between arterial diseases like atherosclerosis and venous diseases such as VTE. Shared risk factors include age, obesity, diabetes, and metabolic syndrome. Atherosclerosis may promote venous thrombotic disorders, and both conditions can be triggered by common biological stimuli that activate coagulation and inflammatory pathways. Patients with unexplained VTE are at higher risk for cardiovascular diseases, indicating a need for further research to understand this association and its clinical implications.
Vascular disease is a complex and multifaceted condition influenced by a variety of lifestyle and endogenous factors. Understanding the mechanisms of vascular remodeling, the role of platelet-leukocyte interactions, and the specific impacts of conditions like diabetes and PAD is crucial for developing effective treatments. Continued research and improved clinical practices are essential to manage and mitigate the significant health burden posed by vascular diseases.
Most relevant research papers on this topic